Dr. Paul Resnick
Privately held clinical-stage Biotech Company, Juventas Therapeutics, has hired Dr. Paul Resnick as its Vice President of Business Development.
Resnick is a veteran in the biotech world having played key roles in Pfizer’s acquisition of Rinat Neurosciences in 2007 and, more recently, Takeda’s acquisition of Intellikine.
President and CEO of Juventas, Rahul Aras, said: "We are delighted to welcome Paul to Juventas' senior management team," adding that Juventas’ development of its natural stem-cell enhancer platform, JVS-100, will reap the benefit of Resnick’s experience.